Three-year study will test biopsy analysis tool shown in trials to identify men likely to benefit from certain drugs A tool that uses artificial intelligence to help diagnose men with prostate cancer and guide decisions about treatment is to be tested in NHS hospitals, researchers have announced. The £1.9m Vanguard Path study, funded by Prostate Cancer UK and led by researchers at the University of Oxford, is expected to last three years and will test an AI tool called the ArteraAI Prostate Biopsy Assay. In total, biopsies from more than 4,000 men will be used. Continue reading...

The AI company’s app Sora makes a bigger splash than Meta’s Vibes. Plus, everything I learned about the Tesla CEO in the past 12 months

Poll of 2,000 people appears to underline experts’ concerns of growing ‘epidemic’ of addiction to alcohol or drugs One in four people in the UK fear that a partner, relative or friend drinks too much, while one in six worry that a loved one is taking too many drugs. The findings, from a representative survey of 2,000 adults, appear to underline what some experts say is a growing “epidemic” of addiction to alcohol or drugs such as cocaine and cannabis. 10% worry that they drink too much and 5% that they use drugs too often. 26% worry that a partner, family member or friend drinks too much. 16% are concerned about a loved one’s use of illegal drugs. Families that earn more than £50,000 a year are three times more likely to contain someone with an addiction problem. Continue reading...